Literature DB >> 16080076

Primary cytomegalovirus infection, atypical Kawasaki disease, and coronary aneurysms in 2 infants.

Charlotte Catalano-Pons1, Pierre Quartier, Marianne Leruez-Ville, Florentia Kaguelidou, Dominique Gendrel, Gérard Lenoir, Jean-Laurent Casanova, Damien Bonnet.   

Abstract

We describe 2 infants who developed atypical Kawasaki disease and coronary aneurysms during primary cytomegalovirus infection. These observations suggest that children with coronary aneurysms and Kawasaki-like disease should be tested for cytomegalovirus. Conversely, children with unusually severe primary cytomegalovirus infection should be tested for coronary aneurysms.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16080076     DOI： 10.1086/432578

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  11 in total

1.  Unusual imaging presentation of infantile atypical Kawasaki disease.

Authors:  Nishith Kumar; Mahesh Kumar Mittal; Mukul Sinha; Arpita Gupta; Brij Bhushan Thukral
Journal:  Indian J Radiol Imaging       Date:  2016 Jul-Sep

2.  Evaluating Postoperative Outcomes of Patients Undergoing Elective Procedures in an Ambulatory Surgery Center During the COVID-19 Pandemic.

Authors:  Rafael A Couto; Thomas C Wiener; William P Adams
Journal:  Aesthet Surg J       Date:  2020-06-29       Impact factor: 4.283

3.  Kawasaki syndrome and concurrent Coxsackie virus B3 infection.

Authors:  Donato Rigante; Luca Cantarini; Marco Piastra; Donatella Francesca Angelone; Piero Valentini; Manuela Pardeo; Danilo Buonsenso; Angelica Bibiana Delogu; Daniele Serranti; Alessia De Nisco; Adele Compagnone; Gabriella De Rosa
Journal:  Rheumatol Int       Date:  2010-10-30       Impact factor: 2.631

4.  Does reactivation of cytomegalovirus contribute to severe COVID-19 disease?

Authors:  Cecilia Söderberg-Nauclér
Journal:  Immun Ageing       Date:  2021-03-12       Impact factor: 6.400

5.  Characterization of the gut microbiota of Kawasaki disease patients by metagenomic analysis.

Authors:  Akiko Kinumaki; Tsuyoshi Sekizuka; Hiromichi Hamada; Kengo Kato; Akifumi Yamashita; Makoto Kuroda
Journal:  Front Microbiol       Date:  2015-08-11       Impact factor: 5.640

6.  COVID-19 and Kawasaki syndrome: should we really be surprised?

Authors:  Rohit S Loomba; Enrique Villarreal; Saul Flores
Journal:  Cardiol Young       Date:  2020-06-25       Impact factor: 1.093

Review 7.  Kawasaki disease: aetiopathogenesis and therapeutic utility of intravenous immunoglobulin.

Authors:  Caroline Galeotti; Jagedeesh Bayry; Isabelle Kone-Paut; Srinivas V Kaveri
Journal:  Autoimmun Rev       Date:  2010-01-13       Impact factor: 9.754

8.  Cytomegalovirus infection in a patient with atypical Kawasaki disease.

Authors:  Belgin Usta Guc; Nurcan Cengiz; Selman Vefa Yildirim; Yasemin Uslu
Journal:  Rheumatol Int       Date:  2007-08-24       Impact factor: 2.631

Review 9.  Searching for the cause of Kawasaki disease--cytoplasmic inclusion bodies provide new insight.

Authors:  Anne H Rowley; Susan C Baker; Jan M Orenstein; Stanford T Shulman
Journal:  Nat Rev Microbiol       Date:  2008-05       Impact factor: 60.633

10.  Association between SARS-CoV-2 infection and Kawasaki-like multisystem inflammatory syndrome: a retrospective matched case-control study, Paris, France, April to May 2020.

Authors:  Julie Toubiana; Corinne Levy; Slimane Allali; Camille Jung; Marianne Leruez-Ville; Emmanuelle Varon; Fanny Bajolle; Naim Ouldali; Judith Chareyre; Stephane Béchet; Annie Elbez; Jean-Laurent Casanova; Martin Chalumeau; Robert Cohen; Jérémie F Cohen
Journal:  Euro Surveill       Date:  2020-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.